Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Cash from Operations (2023 - 2026)

Rallybio's Cash from Operations history spans 3 years, with the latest figure at 4679000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations rose 52.56% to 4679000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 29813000.0, a 39.51% increase, with the full-year FY2025 number at 29813000.0, up 39.51% from a year prior.
  • Cash from Operations hit 4679000.0 in Q4 2025 for Rallybio, up from 6550000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for RLYB hit a ceiling of 4679000.0 in Q4 2025 and a floor of 18765000.0 in Q1 2023.
  • Historically, Cash from Operations has averaged 11613333.33 across 3 years, with a median of 11031500.0 in 2023.
  • Biggest five-year swings in Cash from Operations: increased 15.31% in 2024 and later surged 52.56% in 2025.
  • Tracing RLYB's Cash from Operations over 3 years: stood at 11645000.0 in 2023, then rose by 15.31% to 9862000.0 in 2024, then soared by 52.56% to 4679000.0 in 2025.
  • Business Quant data shows Cash from Operations for RLYB at 4679000.0 in Q4 2025, 6550000.0 in Q3 2025, and 8379000.0 in Q2 2025.